Patent details

Basic Information

Publication number:

EP1244647

PCT Application Number:

PCT/GB/2000/004181

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP009746678

PCT Publication Number:

WO/2001/032651

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

QUINAZOLINE DERIVATIVES AS VEGF INHIBITORS

French Title of Invention:

DERIVES DE QUINAZOLINE UTILISES EN TANT QU'INHIBITEURS DU FACTEUR DE CROISSANCE ENDOTHELIALE VASCULAIRE (VEGF)

German Title of Invention:

QUINAZOLIN-DERIVATE ALS VEGF-HEMMER

SPC Number:

92057

Dates

Filing date:

01/11/2000

Grant date:

21/06/2006

EP Publication Date:

21/06/2006

PCT Publication Date:

10/05/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

02/10/2002

EP B1 Publication Date:

21/06/2006

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

01/11/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

03/11/2016

 

 

Name:

GENZYME CORPORATION

Address:

KENDALL STREET 500, CAMBRIDGE, MA 02142, United States (US)

History of Owners

From:

01/11/2000

To:

02/11/2016

Name:

AstraZeneca AB

Address:

-, 151 85 Södertälje, Sweden (SE)

Agent

1

Name:

ARONOVA S.A.

From:

03/11/2016

Address:

PO Box 327, 4004, ESCH-SUR-ALZETTE, Luxembourg (LU)

To:

2

Name:

VAN MALDEREN JOELLE

From:

02/08/2006

Address:

ROUTE D'ARLON 261, 8002, STRASSEN, Luxembourg (LU)

To:

02/11/2016

Inventor

1

Name:

Hennequin Laurent François André

Address:

France (FR)

2

Name:

Thomas Andrew Peter

Address:

United Kingdom (GB)

3

Name:

Stokes Elaine Sophie Elizabeth

Address:

United Kingdom (GB)

Priority

1

Priority Number:

99402759

Priority Date:

05/11/1999

Priority Country:

European Patent Office (EPO) (EP)

2

Priority Number:

99402877

Priority Date:

19/11/1999

Priority Country:

European Patent Office (EPO) (EP)

Classification

Main IPC Class:

C07D 401/12;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

24/10/2019

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

CPA GLOBAL THE IP PLATFORM

Filing date	Document type	Number of pages